Concord Medical Services Stock Pattern Recognition Short Line Candle
| CCM Stock | USD 3.86 0.20 5.46% |
| Symbol |
Recognition |
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of nine valid pattern recognition events for the selected time horizon. The Short Line Candle pattern describes signals for either bullish or bearish trend during either reversal or continuation condition of Concord Medical Services.
Concord Medical Technical Analysis Modules
Most technical analysis of Concord Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Concord from various momentum indicators to cycle indicators. When you analyze Concord charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people. A high-level view of Concord Medical emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 3.0, profit margin of -44.6%. Concord Medical has a market cap of 16.74 M, ROE of -29.03%. 
Gabriel Shpitalnik ยท Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Concord Medical Services is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Concord (USA Stocks:CCM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Concord Medical Services is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Concord Medical Services may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Concord Stock is Curated By:
Gabriel Shpitalnik ยท Member of Macroaxis Editorial BoardBecome your own money manager
Tracking Concord Medical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested over 20 shares | |
 | Dividend Beast Invested over 40 shares | |
 | Impulse Invested over 200 shares | |
 | Cash Cows Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | FinTech Invested over 20 shares | |
 | Momentum Invested few shares | |
 | Blockchain Invested few shares | |
 | Power Assets Invested over 200 shares |
More Resources for Concord Stock Analysis
A structured review of Concord Medical Services often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Concord Medical Services Stock in context:Concord Medical has a market cap of 16.74 M, operating margin of -72.1%, ROE of -29.03%. Use Trending Equities to explore allocation context. This includes a position in Concord Medical Services across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Analysis related to Concord Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Earnings Share -5.44 | Revenue Per Share | Quarterly Revenue Growth -0.08 | Return On Assets | Return On Equity |
The market value of Concord Medical Services is measured differently than book value, which reflects Concord accounting equity. Concord Medical's market capitalization is 16.74 M. With a P/B ratio of 3.0, the market values Concord Medical well above its book equity. Enterprise value stands at 545.25 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Concord Medical's intrinsic value and market price are different measures derived from different inputs. For Concord Medical, key inputs include a P/B ratio of 3.0, a profit margin of -44.6%, ROE of -29.03%, and revenue of 383.96 M. Trading price represents the transaction level agreed by market participants.